Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr mice by Shiozawa, Fumitaka et al.
R78
Introduction
MRL/Mp-lpr/lpr (MRL/lpr) mice spontaneously develop a
severe autoimmune syndrome resembling systemic lupus
erythematosus (SLE) [1]. The natural history of diffuse pul-
monary involvement seen in MRL/lpr mice as well as SLE
patients has not been clearly defined. Moreover, the mech-
anisms underlying leukocyte infiltration into the lungs of
MRL/lpr mice, especially the roles of chemokines, are still
unknown.
Chemokines belong to a gene superfamily of chemotactic
cytokines that share substantial homology of four con-
served cysteine amino acid residues [2–4]. The CXC family
of chemokines (e.g. interleukin 8 [IL-8], growth-regulated
oncogene [GRO], and interferon [IFN]-γ-inducible protein
10 [IP-10]), in which the first two cysteines are separated
by another amino acid residue, is chemotactic for neu-
trophils and T cells. On the other hand, the CC chemokine
family (e.g. macrophage inflammatory protein [MIP]-1,
DN = double negative; H & E = hematoxylin and eosin; IFN = interferon; IL = interleukin; IP-10 = interferon-γ-inducible protein 10; MIP =
macrophage inflammatory protein; PBS = phosphate-buffered saline; PCR = polymerase chain reaction; RT-PCR = reverse transcriptase PCR; SEM =
standard error of the mean; SLE = systemic lupus erythmatosus; TARC = thymus- and activation-regulated chemokine; Th1 = T helper type 1; Th2 =
T helper type 2.
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Abstract
MRL/Mp-lpr/lpr (MRL/lpr) mice spontaneously develop
systemic lupus erythematosus (SLE)-like disease. The natural
history of the pulmonary involvement and the underlying
mechanism of leukocyte infiltration into the lungs of MRL/lpr
mice and SLE patients remains elusive. We aimed to
investigate the expression profiles of chemokines and
chemokine receptors in the lung of the SLE-prone mouse. We
examined the correlation between lung inflammation and
expression of IP-10 (interferon-γ-inducible protein 10), a CXC
chemokine, and TARC (thymus- and activation-regulated
chemokine), a CC chemokine, in MRL/lpr mice, MRL/Mp-+/+
(MRL/+) mice, and C57BL/6 (B6) control mice. The extent of
cell infiltration in the lung was assessed histopathologically.
Reverse transcriptase PCR showed up-regulation of IP-10
mRNA expression in the lungs (P < 0.05) of MRL/lpr mice, in
comparison with MRL/+ or B6 mice. The increase paralleled
increased expression of a specific IP-10 receptor, CXCR3, and
correlated with the degree of infiltration of mononuclear
lymphocytes. In contrast, lung expression of TARC and its
specific receptor, CCR4, were suppressed in MRL/lpr mice.
Immunohistology showed that macrophage-like cells were the
likely source of IP-10. Flow cytometric analyses revealed that
the CXCR3-expressing cells were mainly infiltrating CD4
T cells and macrophages, which correlated with the degree of
mononuclear lymphocyte infiltration. Recent data suggest that
Th1 cells and Th1-derived cytokines play an important role in
the development of SLE-like disease in MRL/lpr mice. Our
results suggest that IP-10 expression in the lung is involved,
through CXCR3, in the pathogenesis of pulmonary
inflammation associated with migration of Th1 cells.
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macrophage chemoattractant protein-1, and regulated on
activation, normal T-cell expressed and secreted
[RANTES]), in which the first two cysteine residues are
juxtaposed, is chemotactic for monocytes and subpopula-
tions of T cells. The chemokines appear to play key roles
in inflammatory and immune responses mediated by their
respective affected cell populations.
IP-10, a member of the CXC chemokine family, is
expressed and secreted by monocytes, fibroblasts, and
endothelial cells after stimulation with IFN-γ [2,5] and has
important roles in the migration of T cells into inflamed
sites. IP-10 also promotes the regression of angiogenesis,
in contrast to IL-8 [6,7].
The immune/inflammatory responses and pathogenesis of
certain diseases correlate with the balance between T
helper type 1 (Th1) and T helper type 2 (Th2) responses
[8–10]. A Th1/Th2 cytokine imbalance with a predomi-
nance of Th1 cytokines, including IFN-γ, is suggested to
be of pathogenetic importance in autoimmune diseases,
such as rheumatoid arthritis and SLE [11–13], while pre-
dominance of Th2 cytokines, including IL-4, is important in
allergic reactions, such as bronchial asthma [14]. Recent
evidence indicates that receptor expression dictates the
spectrum of action of chemokines, as shown for Th1 and
Th2 cells. The Th1 phenotype expresses certain
chemokine receptors, including CXCR3 and CCR5,
ligands for IP-10 and MIP-1β, respectively [15,16], while
the Th2 phenotype expresses CCR4 and CCR8, ligands
for thymus- and activation-regulated chemokine (TARC)
and macrophage-derived chemokine and MIP-1β, respec-
tively. Further studies demonstrated that polarized T cells
differentially respond to IP-10 for Th1 cells and to
macrophage-derived chemokine for Th2 cells [17,18].
Although some evidences exist for the importance of Th1
cytokines in the pathogenesis of SLE-like disease in
MRL/lpr mice, the specific profiles of IP-10, of ligand for
chemokine receptor, and of CXCR3 of Th1 phenotype in
various aspects of murine lupus remain incompletely
resolved. In the present study, we focused on the expres-
sion profiles of IP-10 and CXCR3 as the pathological
mechanism of pulmonary involvement in the lupus-prone
mouse, through the regulation of Th1/Th2 polarization.
Materials and methods
Animals and reagents
Female MRL/Mp-lpr/lpr (MRL/lpr), MRL/Mp-+/+ (MRL/+)
and C57BL/6 (B6) mice were purchased from the Charles
River Japan (Yokohama, Japan) and bred in our facility.
MRL/+ mice, which have the same genetic background as
MRL/lpr mice but lack the lpr mutation, and B6 mice were
used as disease control against MRL/lpr mice. Goat
antimurine IP-10 and rabbit antimurine CXCR3 polyclonal
antibodies and preimmune control antibodies were pur-
chased from Genzyme/Techne (Cambridge, MA, USA)
and Zymed Laboratories (South San Francisco, CA, USA),
respectively. Monoclonal rat anti-Mac-3 antibody detects
murine macrophages (BD PharMingen, San Diego, CA,
USA). Animal experimentation was performed in accor-
dance with protocols approved by the Animal Care Com-
mittee of Showa University.
Evaluation of pulmonary inflammation
Lungs were inflated with 1 ml of physiologic saline and fixed
with 4% paraformaldehyde, and paraffin sections were pre-
pared and stained with H & E. Pulmonary infiltration and
inflammation were evaluated using a scoring system similar
to the pathological scoring system described previously.
Briefly, the perivascular and peribronchiolar infiltrates were
assessed semiquantitatively in >10 vessels per section and
in >10 bronchioli per section (score: 0 = none; 1 = less
than three cell layers surrounding <50%; 2 = three to six
cell layers surrounding >50%; 3 = more than six layers), in
accordance with protocol reported by Tesch and col-
leagues [19]. In addition, the infiltrates in alveolar area were
assessed in 20 high-power fields/section (score: 0 = none;
1 = 10 infiltrating mononuclear cells; 2 = 20 infiltrating
cells; 3 = more than 20 infiltrating cells) based on the proto-
col described by Seggev and colleagues [20].
Immunohistochemical study
Lung tissues were inflated with optimal cutting tempera-
ture (OCT) compound (Tissue-Tek II, Miles Laboratories,
Naperville, IL, USA) and snap frozen. Before staining,
5 µm frozen sections were fixed for 30 min in ice-cold
acetone. Endogenous peroxidase activity was quenched
by incubating the slides for an additional 30 min in
absolute methanol and 3% hydrogen peroxide. The slides
were then incubated with polyclonal antibodies against
murine IP-10 or murine Mac-3, or appropriate control IgG.
Biotinylated antirabbit or antirat IgG (Biogenex, San
Ramon, CA, USA) and peroxidase-conjugated streptavidin
were used as second and third reagents, respectively,
while the optimal color was developed using a 3,3-
diaminobenzidine tetrahydrochloride (DAB) detection kit
(Nichirei, Japan). After rinsing with distilled water, the
slides were counterstained with Mayer’s hematoxylin.
Isolation of tissue RNA, reverse transcriptase PCR, and
Southern blotting
Total RNA was extracted from the lungs or axillary lymph
nodes using TRIzol reagent (Invitrogen, San Diego, CA,
USA), and reverse transcriptase PCR (RT-PCR) was per-
formed as described previously [21]. Briefly, 5 µg of total
RNA was reverse transcribed using M-MLV reverse tran-
scriptase (TaKaRa, Kyoto, Japan). PCR was carried out for
35 cycles, after which the amplified DNA fragments were
subjected to 2% agarose gel electrophoresis. For South-
ern blot analysis, some products were transferred to nylon
filters, and then the filters were hybridized with syntheticArthritis Research & Therapy    Vol 6 No 1 Shiozawa et al.
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32P-5′ end-labeled internal oligoprobes that recognized
sequences between the two primers. The primers and
internal probe sequences were as follows: IP-10 primers —
sense 5-CTT-GAA-ATC-ATC-CCT-GCG-AGC, antisense
5-TAG-GAC-TAG-CCA-TCC-ACT-GGG, internal probes,
5-GGA-GAG-AAG-CCA-CGC-ACA-CAC; CXCR3 primers —
sense 5-TTT-GAC-AGA-ACC-TTC-CTG-CCA-G, antisense
5-AAA-CCC-ACT-GGA-CAG-CAG-CAT-C, internal probes,
5-GCC-CTC-TAC-AGC-CTC-CTC-T; TARC primers —
sense 5-CAG-GAA-GTT-GGT-GAG-CTG-GTA-TA, anti-
sense 5-TTG-TGT-TCG-CCT-GTA-GTG-CAT-A; CCR4
primers — sense 5-TCT-ACA-GCG-GCA-TCT-TCT-TCA-T,
antisense 5-CAG-TAC-GTG-TGG-TTG-TGC-TCT-G; IFN-γ
primers — sense 5-CTC-AAG-TGG-CAT-AGA-TGT, anti-
sense, 5-GAG-ATA-ATC-TGG-CTC-TGC-AGG-ATT; and
IL-4 primers — sense 5-CAG-CTA-GTT-GTC-ATC-CTG-
CTC-TTC, antisense 5-GCC-GAT-GAT-CTC-TCT-CAA-
GTG-A
Three-color flow cytometric analyses for chemokine
receptors and leukocyte surface markers
For harvesting lung-infiltrating leukocytes, the right lung was
perfused with PBS, dissected out en bloc from the chest
cavity, and then minced with scissors. Each sample was
incubated for 30 min at 37°C on a rocker in 10 ml digestion
buffer (Dulbecco’s modified Eagle’s medium with 10% fetal
bovine serum and 1% collagenase). The cell suspension
and undigested fragments were further dispersed by
drawing them up and down through the bore of a 10-ml
syringe. Cells were washed in 1 × PBS and resuspended at
a density of 1 × 106 cells/ml in PBS containing 2% fetal
bovine serum. The viability of dispersed cells from these
preparations was greater than 85–90% as confirmed by
trypan blue dye exclusion.
After incubation with Fc block (BD PharMingen) for
15 min, the cells were further stained with the specified
antibody (anti-CD3-FITC, anti-CD4-PE, CD8-PE, anti-
B220-PE, or antimacrophage-FITC, purchased from BD
PharMingen and Serotec, Raleigh, NC, USA, respectively)
at a concentration of 10 µg/ml, or rabbit anti-CXCR3 anti-
body (10 µg/ml), and then the second antibody (biotin-
conjugated antirabbit IgG) and third reagent
(CyChrome-conjugated streptavidin from BD PharMin-
gen). An isotype control antibody conjugated with the
respective fluorescent or biotinylation tag was used for
negative control staining of each specific antibody. After
30 min on ice, the cells were washed with PBS and the
fluorescence intensity was measured on a three-color
FACScan flow cytometer (Becton Dickinson, Mountain
View, CA, USA). Finally, the data were analyzed using Cel-
lQuest computer software (Becton Dickinson).
Statistical analysis
Data were analyzed on a Power Macintosh® computer
using a statistical software package (StatView, Abacus
Concept, Inc, Berkeley, CA, USA) and expressed as
mean ± SEM. Data groups were compared by analysis of
variance; parameters whose variances were determined to
be significantly different were then compared by Student’s
t-test. A P value less than 0.05 denoted the presence of a
statistically significant difference.
Results
Evaluation of pulmonary inflammation and phenotype
analyses of infiltrating cells in lung
We first examined the development of pulmonary inflamma-
tion in MRL/lpr, MRL/+ and B6 mice. Since MRL/lpr mice
develop severe pulmonary inflammation with advancement
of age, mice were humanely killed at the age of 4 months
and their lungs were prepared for histopathological analy-
sis. Fig. 1 shows representative histopathological sections
(Fig. 1a) and the pathology scores (Fig. 1b) of lungs from
each group. The mononuclear cell infiltration of the pul-
monary perivascular and peribronchial lesions and of the
alveolar area of MRL/lpr mice was significantly greater than
in MRL/+ or B6 mice (Fig. 1). These results are in agree-
ment with those reported previously [19,22].
Cells obtained from the whole lung preparation from mice
at the age of 1 or 4 months were diluted and stained with
appropriate antibodies for phenotype analysis using flow
cytometry. As shown in Fig. 2, the percentages of
CD4+CD3+ T cells and CD4–CD8– B220+CD3+ T cells
(double negative [DN] B220+ T cells) were greater in 4-
month-old MRL/lpr mice than in MRL/+ and B6 mice.
Conversely, the proportion of macrophages in the lungs
was significantly lower in the 4-month-old MRL/lpr mice
than in the other two mouse groups, indicating that the
increase of these infiltrating T cells may be responsible for
the low number of macrophages in lung. These results
indicate that the development of tissue injury in MRL/lpr
mice is characterized by the accumulation of T cells, espe-
cially DN B220+ T cells and CD4+CD3+ T cells, which
may contribute to the development of the pulmonary
inflammation seen in MRL/lpr mice [19,23].
Expression pattern of IP-10 and CXCR3 in the lungs
The above histopathological pattern in MRL/lpr mice
appeared to correlate with the influx into the lungs of
mononuclear cells, especially DN B220+ and CD4+
T cells. Since it has been demonstrated that IFN-γ is up-
regulated during organ inflammation and damage is seen
in MRL mice [24,25], we postulated that IP-10, especially
IFN-γ-related chemokines, may be involved in the recruit-
ment of infiltrating cells and in the development of sponta-
neous lupus-like clinical features of the murine MRL/lpr.
Therefore, using semiquantitative RT-PCR and Southern
blotting, we examined the serial changes in the expression
of IP-10 and CXCR3, its specific receptor, during the
development of pulmonary infiltration. As shown in Fig. 3,
IP-10 mRNA expression in the lung of MRL/lpr miceincreased in an age-dependent fashion and correlated
with the development of pulmonary inflammation as
defined by mononuclear cell infiltration, in comparison with
these phenomena in MRL/+ and B6 mice. In MRL/lpr
mouse lung, immunolocalization showed IP-10 (Fig. 4a,
arrows) to be mainly associated with infiltrating mononu-
clear cells, especially macrophage-like cells surrounding
the lesion of lymphocytic infiltration, identified by morphol-
ogy and by reactivity with anti-Mac-3 antibody (Fig. 4b,
arrowheads). On the other hand, tissue sections stained
with preimmune control IgG showed little or no specific
staining (results not shown). We also examined the
expression pattern of CXCR3 transcripts. Interestingly,
although a weak expression of CXCR3 transcript was
seen in the lungs of B6 mice, the expression pattern in the
Available online http://arthritis-research.com/content/6/1/R78
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Figure 1
Pulmonary infiltration and inflammation in MRL/lpr, MRL/+, and B6 mice. The lungs of 4-month-old mice were stained with hematoxylin and eosin. 
(a) Representative histopathological sections and (b) the pathology scores of lungs of each mouse are shown. Pathology scores are expressed as
mean ± SEM of at least 15 sections from five mice of each mouse strain. There was significantly greater mononuclear cell infiltration into the
pulmonary perivascular and peribronchial lesions and the alveolar area of MRL/lpr mice than in the MRL/+ (*P < 0.05) or B6 (**P < 0.01) mice.
(Original magnification: 100×).
Figure 2
Phenotype analyses of infiltrating cells in the lungs of MRL/lpr, MRL/+,
and B6 mice. Cells obtained from whole lung preparations from 1- and
4-month-old mice (n = 5 per group) were stained by appropriate
antibodies for phenotype analysis using flow cytometry. Data are
expressed as percentages of cells, as described in Materials and
methods. The percentages of CD4+CD3+ T cells and CD4–CD8–
B220+CD3+ T cells (double negative [DN] B220+ T cells) were
significantly increased, by 15.2% and 22.7%, respectively, in 4-month-
old MRL/lpr mice in comparison with MRL/+ and B6 mice (*P < 0.05).
Figure 3
Time course of IP-10 transcription in MRL/lpr, MRL/+, and B6 mice.
Whole RNA was isolated from mouse lung tissues at the indicated
times (months); transcribed mRNA was amplified by RT-PCR. 
(a) Representative expression of IP-10 mRNA and Southern blot
hybridization with internal probes; GAPDH primers were used as an
internal control. Data are representative of three independent
experiments. Lane M: molecular weight markers (100-base-pair
ladder). (b) IP-10 transcripts were quantitated and normalized to
GAPDH as IP-10/GAPDH transcripts ratio. Data are expressed as
mean ± SEM of three independent experiments; *P < 0.05 vs individual
age (4 months) of MRL/+ mice and B6 mice. GAPDH, glyceraldehyde-
3-phosphate dehydrogenase; IP-10, interferon-γ-inducible protein 10;
PCR, polymerase chain reaction; RT-PCR, reverse transcriptase PCR.lungs of MRL/lpr mice was higher than in MRL/+ mice and
was correlated with the age-related changes in the expres-
sion of IP-10 (Fig. 5a,b).
Phenotype analyses of CXCR3-expressing infiltrating
cells
To further examine the phenotype of cells expressing
CXCR3, we analyzed the expression of CXCR3 as well as
CD3, CD4, B220, and macrophages on migrating leuko-
cytes isolated from the lungs, by flow cytometry (Fig. 6). In
lungs of 4-month-old MRL/lpr mice, CXCR3 expression
was significantly elevated on CD4+CD3+ T cells and
macrophages. Furthermore, the up-regulated expression
was age-dependent, correlated with the degree of inflam-
mation scores of the lungs, and paralleled the expressional
patterns of both IP-10 and CXCR3 (Figs 2, 3, and 5). The
relative numbers of CXCR3-expressing CD8+ T cells and
B220+ T cells in MRL/lpr mice were higher, though not
significantly higher, than those in MRL/+ and B6 mice.
Expression of TARC and CCR4 in pulmonary
inflammation and determination of polarization of Th
responses by IFN-γ γ/IL-4 expression
To elucidate more clearly the dysregulation between Th1
and Th2 cytokines in the pathogenesis of murine lupus, we
examined the profiles of the expression of TARC (Th2 type
chemokine) and its receptor, CCR4, in the lungs. As
shown in Fig. 7, expression of TARC transcripts was inhib-
ited in the lungs of MRL/lpr mice in comparison with the
lungs of normal B6 mice. A similar kinetic pattern for the
expression of CCR4 was observed (Fig. 7c). Taken
together, the above findings demonstrated that the
observed imbalance in the enhanced expression of
IP-10/CXCR3 rather than TARC/CCR4 expression con-
tributed to the progressive lupus-like pathology in the lungs
of MRL/lpr mice. Finally, to confirm the importance of Th1-
dominant responses in lupus-like pathogenesis, mRNA
transcripts of classical Th1 and Th2 cytokines (IFN-γ and
IL-4, respectively) in the lungs and lymph nodes were also
determined (Fig. 8). In MRL/lpr mice, transcripts of IFN-γ
were significantly up-regulated in the lymph nodes (Fig. 8b)
but not in the lungs. In contrast, IL-4 expression was down-
regulated in the lungs (Fig. 8a), but not in the lymph nodes,
in comparison with the expression in MRL/+ mice.
Discussion
MRL/lpr mice develop a spontaneous autoimmune SLE-
like disease, characterized by progressive lymphadenopa-
thy, hypergammaglobulinemia, autoantibody production
and renal injury. Furthermore, as demonstrated previously
and in the present study, the condition is associated with
infiltration of mononuclear cells and inflammation of the
lungs. CD4+ T cells, macrophages and B220+ T cells
seem to be major infiltrating cells in the lungs of MRL/lpr
mice [23,26]. In the present study, we demonstrated
enhanced expression of both IP-10 and its counterpart,
CXCR3, in lungs of MRL/lpr mice, and that such expres-
sion correlated positively with the degree of pulmonary
cell infiltration and inflammation, in comparison with
MRL/+ and non-lupus-prone control mice. Flow cytometric
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Figure 5
Time course of CXCR3 transcription. Whole RNA was isolated from
lung tissues of 1- and 4-month-old MRL/lpr, MRL/+, and B6 mice;
transcribed mRNA was amplified by RT-PCR. (a) Representative
expression of CXCR3 mRNA and Southern blot hybridization with
internal probes; GAPDH primers were used as an internal control.
Data are representative of three independent experiments. Lane M:
molecular weight markers (100-base-pair ladder). (b) CXCR3
transcripts were quantitated and normalized to GAPDH as the
CXCR3/GAPDH transcripts ratio. Data are expressed as mean ± SEM
of three independent experiments; *P < 0.05 vs B6 mice (4 months);
the difference between MRL/lpr and MRL/+ mice (4 months) was not
statistically significant. GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; PCR, polymerase chain reaction.
Figure 4
Immunohistochemical localization of IP-10 in the lung of 4-month-old
MRL/lpr mice. Frozen lung sections were stained with antibodies
against (a) IP-10 and (b) macrophages. The significant presence of
cell-associated IP-10 antigen (a, arrows) seems to contribute to
infiltration of macrophages (b, arrowheads). (Original magnification:
200×). IP-10, interferon-γ-inducible protein 10.analyses of MRL/lpr lungs revealed that the specific cells
expressing CXCR3 were infiltrating CD4+ T cells,
macrophages, DN B220+ T cells and to a lesser extent
CD8+ T cells, which correlated with the degree of infiltra-
tion of mononuclear lymphocytes.
Our results on IFN-γ (Fig. 8) are in agreement with those
of previous studies, which demonstrated elevated levels
of IFN-γ in MRL/lpr lupus-prone mice [25,27–31]. Other
studies indicated that the cell accumulation and inflam-
mation seen in MRL/lpr mice is regulated by IFN-γ recep-
tor signaling pathway [32]. In addition, inhibition of IFN-γ
by deletion of IFN-γ gene or by injection of cDNA encod-
ing IFN-γR/Fc caused disease amelioration of MRL/lpr
mice [30,31,33]. These results suggest that the Th1-type
cytokine IFN-γ likely plays a crucial role in the develop-
ment of murine lupus, as does IL-12, which induces Th1
T cell differentiation and IFN-γ production by T cells [34].
It is believed that Th1 cells and Th1-type cytokines play
an important role in the development of certain rheumatic
diseases. CXCR3 is preferentially expressed in Th1 in
comparison with Th2 cells, and Th1 but not Th2 cells
respond to IP-10 [35–37]. IP-10 and CXCR3 are
expressed in the inflamed synovium of rheumatoid arthri-
tis, and seem to have an important role in the recruitment
of Th1-type cells into the joint cavity [38–40]. Likewise,
increased expression of IFN-γ and predominance of Th1
response are observed in human SLE and further in
another lupus-prone NZB/W mice [27,41], and exacerba-
tion of SLE and lupus-like syndrome in myeloproliferative
disease was induced by treatment with IFN-γ [42,43].
Similar to the findings of the present study, in sarcoidosis,
a disease characterized by a typical cell-mediated Th1-
type inflammatory response, it has been shown that infil-
trating lung T cells express both IFN-γ and CXCR3 but
not IL-4 and CCR4 [44–46]. Taken together, our results
and those of previous studies suggest that IP-10 is
involved in the migration of Th1 cells, through CXCR3, to
the lung and in the development of pulmonary inflamma-
tion and damage.
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Figure 6
Phenotype analyses of CXCR3-expressing infiltrating cells in the lungs of 1- and 4-month-old MRL/lpr, MRL/+, and B6 mice. Mononuclear
leukocytes isolated from the lungs were stained with antibodies against CD3, CD4, CD8, B220, macrophage, or CXCR3. The cells were gated for
either (a) CD3+CD4+, (b) macrophage, (c) CD3+CD8+, or (d) CD3+B220+, and were analyzed for the level of CXCR3 expression by flow
cytometry. (a–d) Histograms of the lungs from 4-month-old mice are representative of three independent experiments. (e) Mean fluorescence
intensity of CXCR3 expression (M2) on gated cells, expressed as mean ± SEM (n = 3); M1, background intensity of isotype-matched control
staining. CXCR3 expression was significantly higher on CD4+CD3+ T cells and macrophages in 4-month-old MRL/lpr mice lungs than in MRL/+
and B6 mice (*P < 0.05).IP-10 seems to be produced preferentially by
macrophages as demonstrated in our immunohistological
study (Fig. 4). Although our study did not directly identify
the factors that regulate the production of IP-10 by
macrophages, we speculate that IP-10 secretion is stimu-
lated by IFN-γ-dependent activation of macrophages,
based on the evidence described above, and also that
IFN-γ is a potent inducer of IP-10 from many cell types [2].
We could not detect a significant difference in the levels
of IFN-γ expression in the lungs of MRL/lpr and control
mice, though such difference was clearly noted in the
lymph nodes (Fig. 8). We are unable to explain the reason
for the insignificant difference in the lung IFN-γ between
MRL/lpr and control mice, and why no significant increase
in IP-10 expression was observed in MRL/+ lung (Fig. 3),
in spite of a similar degree of expression in lung IFN-γ
between MRL/lpr and MRL/+ mice. In this regard, a more
recent study by Ogasawara and colleagues has demon-
strated that IFN-α/β-mediated signals are required for
induction of the IP-10/CXCR3 system in CD8+ T cells
[47]. Therefore, increased IP-10/CXCR3 induction in the
lungs of MRL/lpr mice may be regulated via not only IFN-γ-
but IFN-α/β-dependent signals. Although it is possible that
regulation of IP-10 expression, as well as Th1 responses,
may be mediated by differential mechanisms between lym-
phoid and nonlymphoid tissues, this question needs to be
addressed in future studies.
In contrast to IP-10/CXCR3, the expression of TARC and
CCR4 in the lung of MRL/lpr mice was relatively lower
than in MRL/+ and B6 mice (Fig. 7). The interaction
Arthritis Research & Therapy    Vol 6 No 1 Shiozawa et al.
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Figure 7
Time course of TARC and CCR4 transcription in the lungs of 1- and 4-month-old MRL/lpr, MRL/+, and B6 mice. Whole RNA was isolated from
lung tissues, and transcribed mRNA was amplified by RT-PCR. (a) Representative expression of TARC and CCR4 mRNA; GAPDH primers were
used as an internal control. Data are representative of three independent experiments. Lane M: molecular weight markers (100-base-pair ladder).
(b) TARC and (c) CCR4 transcripts were quantitated and expressed relative to GAPDH as the TARC/GAPDH or CCR4/GAPDH transcripts ratio.
Data are expressed as mean ± SEM of three independent experiments. (b) *P < 0.05 vs 4-month-old B6 mice; **P < 0.01 vs 1-month-old B6 mice.
(c) *P < 0.05 vs 1-month-old MRL/+ mice and 4-month-old MRL/+ mice and B6 mice, **P < 0.01 vs 1-month-old B6 mice. CCR4, TARC receptor;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; RT-PCR, reverse transcriptase polymerase chain reaction; TARC, thymus- and activation-
regulated chemokine.
Figure 8
Determination of IFN-γ and IL-4 transcripts in the lungs and lymph nodes
of 4-month-old MRL/lpr, MRL/+, and B6 mice. Whole RNA was isolated
from lung and lymph node tissues; transcribed mRNA was amplified by
RT-PCR. Representative expression of IFN-γ and IL-4 transcripts in the
lungs (a) and lymph nodes (b); GAPDH primers were used as an
internal control. Data are representative of three independent
experiments. Lane M: molecular weight markers (100-bp ladder).
Transcripts of IFN-γ and IL-4 mRNA were quantitated and expressed
relative to GAPDH as the IFN-γ/GAPDH or IL-4/GAPDH transcripts
ratio. Data are expressed as mean ± SEM of three independent
experiments; (a) *P < 0.05 vs MRL/+ mice; (b) *P < 0.05 vs MRL/+ and
B6 mice. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; RT-
PCR, reverse transcriptase polymerase chain reaction.Available online http://arthritis-research.com/content/6/1/R78
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between  CCR4 and TARC (or macrophage-derived
chemokine) has been described as the primary requirement
for various biological phenomena such as recognition of
memory T cells and recruitment of Th2 cells into the allergic
airway [48]. Collectively, these data indicate the important
role of the IP-10/CXCR3 axis rather than the TARC/CCR4
axis, in the recruitment of specific inflammatory cells into the
lung during pulmonary inflammation in lupus-prone mice. In
contrast to the findings of other investigators and the
present study, Peng and colleagues [33] demonstrated
using cytokine knock-out mice that IL-4 and IFN-γ play a
positive role in the pathogenesis of organ damage and
inflammation in MRL/lpr mice. Other studies demonstrated
that increased expression of IL-4 was seen in B cells of SLE
patients and CD4+ T cells of lupus-prone mice [49]. In addi-
tion, it has been demonstrated that the induction and devel-
opment of experimental lupus is dependent on two stages
of T cell activation and cytokine secretion: an early Th1-domi-
nant stage represented by high IL-2 and IFN-γ expression fol-
lowed later by a Th2-dominant stage represented by
increased expression of IL-4 and IL-10 [50]. Autoantibody
production remains the hallmark of both human and murine
lupus, suggesting a requirement for cytokines produced by
Th2 cells in autoreactive B cell activation. Taken together,
these findings suggest that not only Th1 responses, but also
Th2 responses may be involved in autoimmune-prone mice.
We did not provide a direct demonstration of the role of
the IP-10/CXCR3 pathway in the pathogenesis of pul-
monary infiltration in MRL/lpr mice, and at present it is dif-
ficult to answer how the lpr gene abnormality is associated
with preferential activation of Th1 responses. Available
data in this report and others, however, demonstrated a
good correlation between the relative predominance of
Th1 cells and accelerated development of lupus-like organ
damage, including the lungs and kidneys [24,25,27,28].
We speculate that this mutation modulates the expression
and regulation of cytokines or other molecules involved in
the polarization of Th1 responses.
Conclusion
Recent data suggest that Th1 cells and Th1-derived
cytokines play an important role in the development of the
progressive lupus-like pathology seen in MRL/lpr mice. Our
results suggest that IP-10 expression in the lung plays an
important role in the interstitial pulmonary involvement
associated with the migration of Th1 cells, through CXCR3.
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